個股熱度排行 | 6月13日港股盤前
根據uSMART輿情監測數據，週末期間，市場關注指數最高的5只股票是比亞迪股份、新東方-S、蔚來-SW、百濟神州、藥明康德。
6月13日—港股關注排行TOP5
比亞迪股份
關注度第一爲比亞迪股份，該股上個交易日收盤上漲5.27%，報於315.80港元。近5個交易日累計上漲11.04%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
李錄賣飛比亞迪？套現50億跌破5%披露線 早買6年浮盈遠不及巴菲特
比亞迪“供電”特斯拉，最傷的還是寧德時代
新東方-S
關注度第二爲新東方-S，該股上個交易日收盤下跌1.69%，報於12.80港元。近5個交易日累計上漲26.73%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
新東方找到流量密碼：CEO欽點名師當主播，10萬人涌入直播間，邊學英語邊掃貨
雙語帶貨，新東方找到直播帶貨流量“密碼”？
蔚來-SW
關注度第三爲蔚來-SW，該股上個交易日收盤下跌3.13%，報於154.70港元。近5個交易日累計上漲9.56%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
造車新勢力一季報出齊！蔚來顯疲憊，理想謀盈利，小鵬要高端
安徽六安市與蔚來簽署框架合作協議
百濟神州
關注度第四爲百濟神州，該股上個交易日收盤下跌2.55%，報於95.70港元。近5個交易日累計上漲11.41%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
百濟神州：百澤安®用於治療復發或轉移性鼻咽癌患者的一線治療獲批
百濟神州在2022年歐洲血液學協會年會上展示其日益豐富的血液學產品組合和管線
藥明康德
關注度第五爲藥明康德，該股上個交易日收盤下跌1.59%，報於105.40港元。近5個交易日累計上漲15.51%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
藥明康德控股股東預告減持最多3% 涉近90億元人民幣
股吧炸鍋！3000億巨頭股價暴跌，藥明康德實控人突拋近百億大減持！20萬股民要慌了？有股東違規減持剛被罰
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
